Details for New Drug Application (NDA): 206370
NDA 206370 describes CLOCORTOLONE PIVALATE, which is a drug marketed by Taro and is included in one NDA. It is available from one supplier. Additional details are available on the CLOCORTOLONE PIVALATE profile page.
The generic ingredient in CLOCORTOLONE PIVALATE is clocortolone pivalate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the clocortolone pivalate profile page.
The generic ingredient in CLOCORTOLONE PIVALATE is clocortolone pivalate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the clocortolone pivalate profile page.
Summary for 206370
| Tradename: | CLOCORTOLONE PIVALATE |
| Applicant: | Taro |
| Ingredient: | clocortolone pivalate |
| Patents: | 0 |
Pharmacology for NDA: 206370
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 206370
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOCORTOLONE PIVALATE | clocortolone pivalate | CREAM;TOPICAL | 206370 | ANDA | Sun Pharmaceutical Industries, Inc. | 51672-4166 | 51672-4166-6 | 1 TUBE in 1 CARTON (51672-4166-6) / 45 g in 1 TUBE |
| CLOCORTOLONE PIVALATE | clocortolone pivalate | CREAM;TOPICAL | 206370 | ANDA | Sun Pharmaceutical Industries, Inc. | 51672-4166 | 51672-4166-8 | 1 TUBE in 1 CARTON (51672-4166-8) / 90 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
| Approval Date: | Apr 21, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
